Literature DB >> 9551963

Post-thymic maturation of migrating human thymic single-positive T cells: thymic CD1a- CD4+ T cells are more susceptible to anergy induction by toxic shock syndrome toxin-1 than cord blood CD4+ T cells.

K Imanishi1, K Seo, H Kato, T Miyoshi-Akiyama, R H Zhang, Y Takanashi, Y Imai, T Uchiyama.   

Abstract

To determine whether human CD4+ T cells undergo post-thymic maturation, we compared the susceptibility to anergy induction in human thymic CD1a- CD4+ single-positive (CD4+), cord blood (CB) CD4+, and adult peripheral blood (APB) CD4+ T cells by stimulation with toxic shock syndrome toxin-1 (TSST-1). Most TSST-1-induced T cell blasts derived from either T cell preparation expressed TCR Vbeta2, which determines the potential reactivity to TSST-1. Most thymic CD4+ T cell blast preparations exhibited little or no production of IL-2 and IL-4 after restimulation with TSST-1 and only marginal responses after stimulation with rIL-2 or a combination of PMA and calcium ionophore, while the APB CD4+ T cell blasts showed high responses to these stimuli. The responses of CB CD4+ T cell blasts to these stimuli varied, ranging from minimal to relatively high. Studies of DNA fragmentation showed that there was no significant cell death of thymic CD4+ T cell blasts. Most thymic CD1a- CD4+ and CB CD4+ T cells were CD38 positive. APB CD4+ T cell blasts derived from the CD38+ fraction and from the CD38- fraction exhibited equally high responses to restimulation with TSST-1. These results indicate that thymic CD1a- CD4+ and CB CD4+ T cells are inherently highly susceptible to anergy induction by bacterial superantigens and that thymic CD1a- CD4+ T cells are less mature than CB CD4+ T cells, suggesting that post-thymic maturation in thymic T cells migrating to the periphery is required for acquisition of full reactivity to antigenic stimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551963

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen.

Authors:  N Takahashi; H Kato; K Imanishi; K Miwa; S Yamanami; H Nishida; T Uchiyama
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  A central role for thymic emigrants in peripheral T cell homeostasis.

Authors:  S P Berzins; D I Godfrey; J F Miller; R L Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

3.  Immunological response to cytomegalovirus in congenitally infected neonates.

Authors:  J Hassan; S Dooley; W Hall
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

Authors:  Kajsa Wing; Ann Ekmark; Helen Karlsson; Anna Rudin; Elisabeth Suri-Payer
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

5.  Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.

Authors:  Saori Nakagawa; Koji Kushiya; Ikue Taneike; Ken'ichi Imanishi; Takehiko Uchiyama; Tatsuo Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

6.  Identification and characterization of two novel staphylococcal enterotoxins, types S and T.

Authors:  Hisaya K Ono; Katsuhiko Omoe; Ken'ichi Imanishi; Yoshihiro Iwakabe; Dong-Liang Hu; Hidehito Kato; Naoyuki Saito; Akio Nakane; Takehiko Uchiyama; Kunihiro Shinagawa
Journal:  Infect Immun       Date:  2008-08-18       Impact factor: 3.441

7.  Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood.

Authors:  Wakae Fujimaki; Nozomu Takahashi; Kei Ohnuma; Masayoshi Nagatsu; Hiromi Kurosawa; Satoko Yoshida; Nam H Dang; Takehiko Uchiyama; Chikao Morimoto
Journal:  Clin Dev Immunol       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.